New Risk • Mar 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Earnings have declined by 52% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (NT$3.01b market cap, or US$95.9m). Annuncio • Jan 29
TacBright Optronics Corporation, Annual General Meeting, Jun 11, 2026 TacBright Optronics Corporation, Annual General Meeting, Jun 11, 2026, at 10:00 Taipei Standard Time. Location: 1 floor no,3, k`o pei 2nd rd., jhunan township hsinchu science park, miaoli county Taiwan New Risk • May 04
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 8.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 57% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Market cap is less than US$100m (NT$1.26b market cap, or US$40.8m). Reported Earnings • Apr 24
Full year 2024 earnings released Full year 2024 results: Revenue: NT$1.30b (up 10% from FY 2023). Net loss: NT$92.2m (loss narrowed 54% from FY 2023). Annuncio • Mar 12
TacBright Optronics Corporation, Annual General Meeting, Jun 09, 2025 TacBright Optronics Corporation, Annual General Meeting, Jun 09, 2025, at 10:00 Taipei Standard Time. Location: 1 floor no,3, k`o pei 2nd rd., jhunan township hsinchu science park, miaoli county Taiwan New Risk • Feb 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 54% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (6.3% average weekly change). Market cap is less than US$100m (NT$1.40b market cap, or US$42.4m). New Risk • Dec 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 54% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Market cap is less than US$100m (NT$1.62b market cap, or US$49.9m). Reported Earnings • Apr 16
Full year 2023 earnings released: NT$0.43 loss per share (vs NT$0.049 loss in FY 2022) Full year 2023 results: NT$0.43 loss per share (further deteriorated from NT$0.049 loss in FY 2022). Revenue: NT$1.17b (flat on FY 2022). Net loss: NT$198.4m (loss widened NT$175.6m from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Annuncio • Mar 06
TacBright Optronics Corporation, Annual General Meeting, Jun 05, 2024 TacBright Optronics Corporation, Annual General Meeting, Jun 05, 2024. New Risk • Mar 01
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (NT$2.05b market cap, or US$64.8m). New Risk • Jan 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (5.4% average weekly change). Market cap is less than US$100m (NT$1.96b market cap, or US$62.7m). Reported Earnings • Aug 18
First half 2023 earnings released: NT$0.24 loss per share (vs NT$0.057 profit in 1H 2022) First half 2023 results: NT$0.24 loss per share (down from NT$0.057 profit in 1H 2022). Revenue: NT$551.2m (down 18% from 1H 2022). Net loss: NT$112.3m (down NT$138.7m from profit in 1H 2022). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Reported Earnings • Apr 20
Full year 2022 earnings released: NT$0.05 loss per share (vs NT$0.16 profit in FY 2021) Full year 2022 results: NT$0.05 loss per share (down from NT$0.16 profit in FY 2021). Revenue: NT$1.17b (down 35% from FY 2021). Net loss: NT$22.8m (down 131% from profit in FY 2021). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Buying Opportunity • Apr 17
Now 20% undervalued Over the last 90 days, the stock is up 23%. The fair value is estimated to be NT$7.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.3% over the last 3 years. Meanwhile, the company has become profitable. Buying Opportunity • Mar 02
Now 21% undervalued Over the last 90 days, the stock is up 19%. The fair value is estimated to be NT$7.62, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.3% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to NT$6.09, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 15x in the Chemicals industry in Taiwan. Total returns to shareholders of 40% over the past three years. Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 3 highly experienced directors. No independent directors (9 non-independent directors). Supervisor Bo Zhuang was the last director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Aug 15
First half 2022 earnings released: EPS: NT$0.06 (vs NT$0.005 in 1H 2021) First half 2022 results: EPS: NT$0.06 (up from NT$0.005 in 1H 2021). Revenue: NT$671.8m (down 24% from 1H 2021). Net income: NT$26.4m (up NT$24.1m from 1H 2021). Profit margin: 3.9% (up from 0.3% in 1H 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 71% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 28
Investor sentiment deteriorated over the past week After last week's 20% share price decline to NT$6.99, the stock trades at a trailing P/E ratio of 44x. Average trailing P/E is 18x in the Chemicals industry in Taiwan. Total loss to shareholders of 15% over the past three years. Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 8 experienced directors. 3 highly experienced directors. No independent directors (9 non-independent directors). Supervisor Bo Zhuang was the last director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Apr 10
Full year 2021 earnings released: EPS: NT$0.16 (vs NT$0.038 in FY 2020) Full year 2021 results: EPS: NT$0.16 (up from NT$0.038 in FY 2020). Revenue: NT$1.80b (up 13% from FY 2020). Net income: NT$73.6m (up 313% from FY 2020). Profit margin: 4.1% (up from 1.1% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 125% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 18
First half 2021 earnings released: EPS NT$0.01 (vs NT$0.008 in 1H 2020) The company reported a soft first half result with weaker earnings and profit margins, although revenues improved. First half 2021 results: Revenue: NT$888.9m (up 26% from 1H 2020). Net income: NT$2.33m (down 34% from 1H 2020). Profit margin: 0.3% (down from 0.5% in 1H 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 133% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 29
Full year 2020 earnings released: EPS NT$0.04 (vs NT$0.092 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: NT$1.59b (up 2.8% from FY 2019). Net income: NT$17.8m (down 58% from FY 2019). Profit margin: 1.1% (down from 2.8% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 114% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Is New 90 Day High Low • Feb 18
New 90-day high: NT$6.32 The company is up 10.0% from its price of NT$5.72 on 20 November 2020. The Taiwanese market is up 18% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Chemicals industry, which is up 5.0% over the same period. Annuncio • Jan 28
TacBright Optronics Corp., Annual General Meeting, Jun 25, 2021 TacBright Optronics Corp., Annual General Meeting, Jun 25, 2021. Is New 90 Day High Low • Oct 15
New 90-day high: NT$6.67 The company is up 21% from its price of NT$5.50 on 17 July 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is down 1.0% over the same period.